Trade houses in Macau’s border gate area supplying new crown generic drugs without a license

China News Agency, Macau, January 18 (Reporter Li Yanan) The Drug Administration of the Macao Special Administrative Region Government announced on the 18th that it found 8 places in the border gate area suspected of illegally supplying drugs and illegally importing drugs. Follow up according to law.

According to reports, in response to the development of the new crown epidemic in Macau, the Drug Administration continues to send personnel to inspect pharmacies, and also focuses on inspections of trading houses in the border gate area. During this period, 8 places in the border gate area were found to be suspected of illegally supplying drugs and illegally importing drugs, etc. Drug supervision and management The Bureau has followed up in accordance with the law. Among them, the Food and Drug Administration found in a trading house in the border gate area that it claimed that the new crown oral generic drug Primovir made in India, and the Drug Administration has followed up the behavior of supplying drugs without a license in this place according to law. According to the “Foreign Trade Law”, the Supervision and Administration Bureau will transfer the suspected illegal import cases to the authority department Customs for follow-up.

The Food and Drug Administration pointed out that there are currently only two oral western medicines for the new crown that have been approved for import in Macao, namely Paxlovid Tablet produced by Pfizer Pharmaceuticals and Lagevrio Capsule produced by Merck Pharmaceuticals. The above-mentioned oral medicines approved for import have corresponding contraindications and medication precautions, and are currently only available for prescription by the Health Bureau after import.

The Food and Drug Administration stated that it will monitor the legal supply of drugs on the market through inspections and cross-departmental cooperation with departments including customs, and collect intelligence through different channels. deal with.